Agios Pharmaceuticals Inc... (AGIO)
29.11
-1.17 (-3.86%)
At close: Mar 31, 2025, 10:30 AM
Agios Pharmaceuticals Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | 673.73M | -352.09M | -231.8M | -356.51M | -327.37M | -411.47M | -346.03M | -314.67M | -198.47M | -117.73M | -53.5M | -39.41M | -20.1M | -23.71M |
| Depreciation & Amortization | 5.65M | 6.62M | 8.56M | 9.24M | 9.98M | 8.09M | 7.17M | 6.43M | 5.71M | 3.34M | 1.37M | 1.44M | 1.18M | 801K |
| Stock-Based Compensation | 42.85M | 44.77M | 49.3M | 53.51M | 61.6M | 72.37M | 73.36M | 47.81M | 42.09M | 31.96M | 11.51M | 3.03M | 742K | 371K |
| Other Working Capital | -16.53M | 864K | -9.17M | -38.69M | -59.5M | -39.63M | -22.65M | -29.3M | 167.19M | 5.6M | -20.84M | -25.62M | -38.05M | 16.77M |
| Other Non-Cash Items | -1.09B | 23.69M | -119.1M | 9.54M | 19.52M | 8.53M | -3.82M | 29K | 773K | 572K | 538K | 284K | 297K | 391K |
| Deferred Income Tax | n/a | n/a | n/a | -86.27M | 3.02M | -2.14M | n/a | n/a | n/a | n/a | n/a | 3.84M | 6.71M | -10.66M |
| Change in Working Capital | -19.77M | -19.06M | -16.43M | -36.82M | -71.04M | -46M | -35.1M | -24.83M | 188.47M | 4.91M | -19.26M | -25.59M | -38.37M | 17.58M |
| Operating Cash Flow | -389.84M | -296.06M | -309.48M | -407.32M | -290.76M | -370.62M | -304.42M | -285.23M | 38.56M | -76.95M | -59.35M | -56.4M | -49.55M | -15.22M |
| Capital Expenditures | -1.69M | -999K | -4.88M | -5.74M | -14.91M | -12.17M | -6.99M | -4.63M | -9.91M | -20.16M | -2.22M | -1.29M | -1.48M | -1.91M |
| Acquisitions | n/a | n/a | 132.75M | n/a | 803K | -103.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.54B | -417.93M | -1.03B | -1.38B | -557.03M | -488.57M | -933.32M | -688.7M | -506.07M | -353.18M | -837.22M | -146.05M | -88.52M | -105.94M |
| Sales Maturities Of Investments | 818.38M | 674.68M | 1.15B | 829.8M | 647.68M | 592.18M | 666.48M | 635.42M | 396.63M | 501.65M | 505.53M | 60.13M | 113.04M | 85.48M |
| Other Investing Acitivies | 1.09B | -16.18M | 1.00 | 1.8B | -803K | 103.47M | -266.84M | -53.28M | -109.44M | 148.47M | 571K | -85.92M | 24.52M | n/a |
| Investing Cash Flow | 363.44M | 239.57M | 243.26M | 1.25B | 75.75M | 91.44M | -273.82M | -57.91M | -119.35M | 128.31M | -333.34M | -87.22M | 23.04M | -22.36M |
| Debt Repayment | n/a | n/a | -331K | -578K | -336K | -113K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -802.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 14.44M | 5.43M | 2.68M | 37.3M | 261.85M | 12.52M | 29.82M | 14.86M | 7.63M | 6.37M | 1.58M | -2.24M | 142K | 77.36M |
| Financial Cash Flow | 14.44M | 5.43M | 2.35M | -765.77M | 261.52M | 289.61M | 546.02M | 285.11M | 169.78M | 6.37M | 335.16M | 123.88M | 142K | 77.36M |
| Net Cash Flow | -11.96M | -51.05M | -63.87M | 75.69M | 46.51M | 10.43M | -32.22M | -58.03M | 88.99M | 57.73M | -57.53M | -19.74M | -26.36M | 39.78M |
| Free Cash Flow | -391.53M | -297.06M | -314.36M | -413.06M | -305.67M | -382.79M | -311.41M | -289.86M | 28.65M | -97.11M | -61.57M | -57.69M | -51.02M | -17.13M |